Why Investors Liked Bionano Genomics' Q4 Results

Warren Buffett's right-hand man, Charlie Munger, made waves recently by stating that the Robinhood trading platform "is a dirty way to make money." Investors of at least one popular Robinhood stock -- Bionano Genomics (NASDAQ: BNGO) -- might not bristle too much at Munger's comments simply because they've made so much money. Bionano's shares have soared nearly 188% so far this year.

That momentum could keep going after the company's fourth-quarter update following the market close on Tuesday. The healthcare stock jumped nearly 6% in after-hours trading. Here are the highlights from Bionano's Q4 update.

Image source: Getty Images.

Continue reading

Source Fool.com